
Illuminating the Path: Genetic Testing for Intellectual Disability, Autosomal Recessive 44
Uncover IDAR44's genetic roots with precision testing. Explore diagnosis, counseling, and interventions for improved cognitive and adaptive functioning today.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Uncover IDAR44's genetic roots with precision testing. Explore diagnosis, counseling, and interventions for improved cognitive and adaptive functioning today.

Uncover how genetic testing aids in diagnosing Intellectual Disability, Autosomal Recessive 45, facilitating early interventions, personalized treatments, and informed family…

Explore how genetic testing helps diagnose and manage Intellectual Disability, Autosomal Recessive 46, offering insights into early diagnosis, family planning, and personalized…

Explore Intellectual Disability, Autosomal Recessive 47, FMN2 gene mutations, and the role of genetic testing in early diagnosis, personalized care, and family planning.

Unlock the genetic factors of Juvenile-Onset Diabetes & Neurodegeneration Syndrome. Genetic testing offers diagnostic clarity and critical insights for management.

Explore the role of genetic testing in diagnosing decreased urinary kallikrein activity. Learn how it aids in personalizing treatment and predicting disease progression.

Explore how genetic testing aids in diagnosing and managing Ketoacidosis due to Monocarboxylate Transporter-1 Deficiency. Learn about novel genetic variants and personalized care.

Genetic testing illuminates the diagnosis and management of LKENP, a rare disorder involving neurological decline and ovarian failure, through AARS2 gene insights.